Exo Imaging

Santa Clara, California, United States All United States companies → — Founded 2015

Imaging AI Specialist Medical Device / Hardware Point-of-Care Diagnostics

Cardiology Pulmonology Radiology

Clinical Decision Support & Reference Radiology & Imaging AI

Series C

Claim this company

About Exo Imaging

Exo Imaging is a pioneering healthcare AI company dedicated to modernizing medical imaging through its high-performance handheld ultrasound platform and artificial intelligence. The company’s mission is to make high-quality, affordable, and easy-to-use medical imaging accessible to healthcare professionals worldwide, enabling them to make critical, real-time decisions that ultimately improve patient outcomes.

Exo’s technology combines advances in nano-materials, novel sensor technologies, advanced signal processing, and computation with the economies of scale of semiconductor manufacturing. This approach allows them to produce an affordable medical ultrasound platform capable of exceptional image fidelity, penetration depth, and 3D imaging, all within a handheld device. Their ecosystem includes the handheld ultrasound device (Exo Iris®), workflow software (Exo Works®), and AI-powered diagnostic tools like SweepAI™, which has received FDA clearance for cardiac and lung assessment and real-time scanning assistance. Exo aims to disrupt the high-cost medical imaging market by widely diffusing low-cost, high-image-quality point-of-care ultrasound (POCUS).

Focus Areas

Point-of-care ultrasound (POCUS) systems AI-driven ultrasound image interpretation Clinical workflow automation for imaging POCUS education and training Clinical program analytics and revenue optimization Medical device intellectual property and regulatory clearance Handheld ultrasound transducer technology Real-time automated sweep capture Cloud-based POCUS workflow and documentation Clinical analytics for billing and ROI Tele-education and e-learning for POCUS

Business Intelligence

Technology

Proprietary Piezoelectric Micromachined Ultrasonic Transducer (pMUT) chip technology, silicon-based architectures, AI-based ultrasound image interpretation, real-time automated sweep capture (SweepAI™), cloud-based POCUS workflow and documentation platform (Exo Works™), edge computing for on-device AI

What Physicians Need to Know

Point-of-Care Ultrasound (POCUS) Devices

Exo Imaging offers the Exo Iris™, a handheld, portable ultrasound device that provides high-performance medical imaging at a fraction of the size and cost of traditional cart-based systems. It utilizes patented piezoelectric micromachined ultrasound transducer (pMUT) technology for superior image quality and depth penetration.

AI-Driven Ultrasound Image Interpretation

Exo's AI, including SweepAI™, provides real-time feedback and automated interpretation for various conditions. It's trained on over 100,000 real-world POCUS images from emergency rooms and critical care units, allowing for accurate readings even on less-than-perfect scans.

Clinical Workflow Automation for Imaging

Exo Works™ is a cloud-based POCUS workflow solution that streamlines documentation, review, billing, and quality assurance. It integrates with existing EMR and PACS systems, reducing administrative burden and improving efficiency.

POCUS Education and Training

Exo U offers AI-powered, on-demand education within the Exo app, featuring short, instructional videos (TikTok-style) to help clinicians learn and master POCUS image acquisition and interpretation. SweepAI™ also acts as a POCUS coach, providing real-time guidance.

Cardiac AI

Exo's Cardiac AI, available on Exo Iris, provides real-time measurements of left ventricular ejection fraction (LVEF), stroke volume, and Global Longitudinal Strain (GLS). It assists in diagnosing heart failure (including HFpEF and HFrEF), cardiac hypertrophy, cardiomyopathies, valvular disease, and monitoring cardiotoxicity.

Lung AI

Exo's Lung AI helps determine the presence or absence of A-lines, B-lines, pleural effusion, and consolidation/atelectasis in seconds. It has demonstrated improved accuracy in lung ultrasound interpretation, even for less experienced users.

Fluid Management AI

Exo's SweepAI™-based IVC collapsibility analysis, combined with cardiac and lung AI, delivers rapid bedside insights for assessing fluid status, particularly crucial in post-op or sepsis management. It also quantifies myocardial wall thickness for insights into chronic hypertension.

Population Health AI

While specific details on 'population health AI' are less prominent, Exo's overall mission to make medical imaging accessible and affordable through AI-powered POCUS inherently supports broader population health initiatives by enabling earlier diagnosis and improved care in diverse settings, including rural and underserved areas.

Physician Tip

Exo Imaging's solutions, particularly the Exo Iris handheld ultrasound device with its integrated AI (SweepAI™), are designed to empower physicians with immediate, objective data at the point of care. This can significantly reduce diagnostic error, accelerate patient care pathways, and simplify complex image interpretation, even for those new to POCUS. The on-device AI operates without internet, ensuring reliability in various settings. Furthermore, the Exo U education platform provides accessible, real-time training to enhance POCUS proficiency. Physicians can leverage Exo Works™ to streamline administrative tasks, allowing more focus on patient care. The FDA-cleared AI applications for cardiac, lung, bladder, hip, and thyroid conditions offer quick and reliable answers, making it a valuable tool for rapid assessment and decision-making.

Exo Works™ is designed for seamless integration with virtually any DICOM-enabled ultrasound machine and the most common Electronic Medical Record (EMR) and Hospital Picture Archiving and Communication Systems (PACS). This allows for automated saving of imaging and reports, facilitating billing, storage, and collaboration across healthcare IT systems.

Products by Exo Imaging

No products listed for this company yet. Know of one? Suggest it →

What the Web Says

Exo Imaging is a company that develops AI-powered point-of-care ultrasound (POCUS) platforms, with its flagship product being the Exo Iris handheld ultrasound device. The company also offers Exo Works, a workflow software for documenting, reviewing, and billing ultrasound exams. While product reviews highlight the advanced imaging capabilities, AI features, and portability of the Exo Iris, employer reviews indicate a generally negative sentiment regarding work-life balance, pay, and management.

Overall: Mixed

Strengths

High-performance imaging with patented silicon technology and real-time AI.
Compact, cost-effective, and portable compared to traditional cart-based systems.
Intuitive user interface and AI capabilities, making it easy for novice users.
Whole-body coverage with a single 3-in-1 probe, eliminating the need for multiple probes.
Exo Works software streamlines documentation, QA, and billing, and integrates with existing IT infrastructure.
No subscription required for the base Iris device and included AI software.

Limitations

Overall employee sentiment is negative, with concerns about work happiness, pay, and management.
Requires Apple-only mobile compatibility (iPhone 12 or newer, or newest iPad).
Wired workflow with a physical Duo cable.
Documented thermal duty cycle, which may limit continuous scanning.
Less independent current-generation head-to-head evidence compared to some competitors.
Some users on Reddit express concerns about the reliability of connections and the company's business model for other handheld ultrasound devices, though specifically mentioning Butterfly.

Based on reviews from: Suresult, Revelio Labs, Indeed.com, Imaging Technology News, ICE Magazine, YouTube, App Store, Reddit, Capterra, IndexBox, G2

Last updated: 2026-10-17

Videos

News, demos, and interviews about Exo Imaging.

Loading videos...

Videos load interactively. If none appear, search YouTube for Exo Imaging →

View all on YouTube

Press & Coverage

Exo Imaging

Exo Introduces a New Age of Ultrasound with Exo Iris

Exo launched its Exo Iris handheld ultrasound device, emphasizing its high-performance imaging, real-time AI capabilities, and seamless integration with the Exo Works workflow solution.

2023-09

Exo Imaging

Exo® Launches FDA-Cleared AI on Exo Iris™ to Address Heart Failure

Exo announced FDA clearance for its cardiac and lung AI applications on Exo Iris, aiming to accelerate diagnosis and create new care pathways for heart failure patients at the point of care.

2024-04

Exo Imaging

Exo® Wins “Best New Ultrasound Technology Solution” Designation in 2024 MedTech Breakthrough Awards Program

Exo was recognized for its comprehensive medical imaging ecosystem, including Exo Iris, real-time AI, and workflow software, designed to provide immediate insights for diagnoses.

2024-05

MedTech Dive

Exo adds FDA-cleared AI tools to handheld ultrasound system

Exo made new AI tools available on its Iris handheld ultrasound system, cleared by the FDA for analyzing heart and lung images, particularly beneficial for rural and under-resourced settings.

2024-04

Exo Imaging

Exo® Announces Samsung Medison Strategic Collaboration and Welcomes Omar Ishrak to its Board

Exo announced a strategic collaboration with Samsung Medison to co-develop advanced ultrasound solutions, including a strategic equity investment from Samsung and the addition of Omar Ishrak to Exo's board.

2025-05

Radiology Business

Samsung invests in ultrasound imaging startup Exo, which has now raised $320M

Samsung made a strategic equity investment in Exo and partnered to co-develop advanced ultrasound solutions, with Exo having raised over $320 million in funding.

2025-05

Exo Imaging

Exo Launches a New Era in Disease Diagnosis with the First FDA-cleared Ultrasound AI for Detection of Pleural Effusion and Consolidation/Atelectasis

Exo announced the first FDA 510(k) cleared AI for detecting pleural effusion and consolidation/atelectasis, now included on Exo Iris, empowering clinicians with objective data for lung disease diagnosis.

2025-06

Business Wire

Exo Removes the Subscription Barrier for Handheld Ultrasound

Exo announced that Exo Iris is now available with a connected cloud subscription or subscription-free, removing a key adoption barrier and offering flexibility to customers.

2026-08

Frequently Asked Questions

What specific POCUS devices does Exo Imaging offer, and how do they integrate AI for image interpretation in a clinical setting?

Exo Imaging offers the handheld Exo Iris™ device, which is designed to provide high-quality ultrasound imaging at the point of care. The device integrates with Exo's AI platform, allowing for real-time, AI-driven image interpretation to assist clinicians with diagnoses and improve workflow efficiency. This integration aims to make ultrasound more accessible and easier to use for a wider range of healthcare professionals.

How does Exo Imaging's AI technology specifically address cardiac, lung, and fluid management assessments, and what is the evidence of its accuracy and impact on clinical decisions?

Exo Imaging's AI technology is being developed to assist with various assessments, including cardiac, lung, and fluid management. While specific details on the full commercial availability and extensive peer-reviewed evidence for all AI applications are continuously evolving, the company's focus is on providing tools that can aid in the rapid and accurate interpretation of ultrasound images for these critical areas. The goal is to enhance diagnostic confidence and streamline clinical decision-making at the point of care.

What kind of training and educational resources does Exo Imaging provide for physicians and healthcare administrators to effectively utilize their POCUS devices and AI features?

Exo Imaging is committed to supporting clinicians in adopting POCUS and AI. They offer educational resources and training programs designed to help users effectively operate their handheld ultrasound devices and understand the insights provided by their AI platform. These resources aim to ensure that healthcare professionals can confidently integrate Exo's technology into their practice, improving patient care and diagnostic capabilities.

What are the pricing models for Exo Imaging's POCUS devices and AI subscriptions, and what kind of technical support and customer service can we expect?

Exo Imaging's pricing models for their POCUS devices and AI subscriptions are typically structured to accommodate various healthcare settings, though specific details may require direct inquiry. They aim to provide comprehensive technical support and customer service to ensure seamless integration and operation of their technology within clinical workflows. This includes assistance with device usage, troubleshooting, and optimizing the utility of their AI-driven features.

How does Exo Imaging ensure compliance with healthcare regulations (e.g., HIPAA, FDA) for its devices and AI interpretations, especially concerning data privacy and diagnostic accuracy?

Exo Imaging prioritizes compliance with healthcare regulations, including HIPAA for data privacy and FDA clearances for their devices and AI interpretations. They implement robust security measures to protect patient data and adhere to regulatory standards for medical device safety and efficacy. The company is dedicated to ensuring that their AI algorithms are developed and validated to meet high standards of diagnostic accuracy and reliability, providing clinicians with trustworthy tools.

What is Exo Imaging's strategy for partnerships with healthcare systems or other technology providers, and what is the company's long-term stability and vision in the evolving POCUS and AI market?

Exo Imaging actively pursues partnerships with healthcare systems and technology providers to expand the reach and capabilities of their POCUS and AI solutions. Their long-term vision is to revolutionize medical imaging by making it more accessible, intelligent, and integrated into everyday clinical practice. The company demonstrates stability through continuous innovation, strategic collaborations, and a strong focus on addressing unmet needs in the healthcare market.